Related Experiment Videos
The cost-effectiveness of bariatric surgery
1University of Utah Health Sciences Center, Salt Lake City, Utah, USA.
The American Journal of Gastroenterology
|September 23, 2003
Summary
Gastric bypass surgery is a cost-effective treatment for severe obesity, offering significant value per quality-adjusted life-year (QALY). While not cost-saving, it provides a valuable alternative to no treatment for eligible patients.
Area of Science:
- Medical Economics
- Bariatric Surgery
- Public Health
Background:
- Severe obesity (BMI > 40) presents significant health and economic challenges.
- Conservative treatments often fail for individuals with severe obesity.
- Gastric bypass is a surgical option for severe obesity, but its cost-effectiveness requires evaluation.
Purpose of the Study:
- To estimate the cost-effectiveness of gastric bypass surgery compared to no treatment for severe obesity.
- To analyze lifetime costs and outcomes from a payer's perspective.
- To determine the cost per quality-adjusted life-year (QALY) for gastric bypass.
Main Methods:
- A deterministic decision analysis model was employed.
- Lifetime expected costs and outcomes were compared between gastric bypass and no treatment.
- Sensitivity analyses were conducted to assess the impact of variable parameters.
Main Results:
- Gastric bypass was not found to be cost-saving, as treatment costs exceeded medical cost reductions.
- Base case cost-effectiveness ratios ranged from $5,400 to $16,100 per QALY for women and $10,700 to $35,600 per QALY for men.
- Sensitivity analyses indicated that weight loss, quality of life, and complication rates influenced cost-effectiveness in specific subgroups.
Conclusions:
- Gastric bypass is a cost-effective alternative to no treatment for severe obesity, particularly when costs are below $50,000 per QALY.
- The procedure offers significant value for improving long-term health outcomes in eligible patients.
- Cost-effectiveness is influenced by patient characteristics and treatment outcomes.